Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Downhole telemetry system
Modular authoring and visualization of rules using trees
Semiconductor device
Method and apparatus for token-based context caching
Translucent internal graphics enhancement
System and method for passing PLC signals from a first electrical line to a second electrical line
Hydrothermal synthesis of nanocubes of sillenite type compounds for photovoltaic applications and solar energy conversion of carbon dioxide to fuels
  Randomly Featured Patents
System for method for producing synthetic plural word messages
Stormwater control system and related method
Method for tissue perfusion
Rail profile
System and method for evaluating cardiovascular performance in real time and characterized by conversion of surface potential into multi-channels
Electronic device and method to prevent falling of the electronic device
Resin composition for copper-clad laminate, resin-coated copper foil, multilayered copper-clad laminate, and multilayered printed circuit board
Image forming apparatus
2-(pyrazol-3-yl)carbapenem derivatives
Cosmetic container